KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Insulet (PODD) Research & Development (2016 - 2025)

Insulet's Research & Development history spans 16 years, with the latest figure at $90.9 million for Q4 2025.

  • For Q4 2025, Research & Development rose 50.0% year-over-year to $90.9 million; the TTM value through Dec 2025 reached $301.1 million, up 37.11%, while the annual FY2025 figure was $301.1 million, 37.11% up from the prior year.
  • Research & Development reached $90.9 million in Q4 2025 per PODD's latest filing, up from $77.2 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $90.9 million in Q4 2025 to a low of $37.5 million in Q3 2021.
  • Average Research & Development over 5 years is $53.3 million, with a median of $50.2 million recorded in 2023.
  • Peak YoY movement for Research & Development: decreased 15.15% in 2023, then surged 50.0% in 2025.
  • A 5-year view of Research & Development shows it stood at $41.8 million in 2021, then increased by 18.42% to $49.5 million in 2022, then dropped by 15.15% to $42.0 million in 2023, then skyrocketed by 44.29% to $60.6 million in 2024, then soared by 50.0% to $90.9 million in 2025.
  • Per Business Quant, the three most recent readings for PODD's Research & Development are $90.9 million (Q4 2025), $77.2 million (Q3 2025), and $73.4 million (Q2 2025).